Septerna Inc stock is traded at $47.35, with a volume of 533,228. It is down -1.11% in the last 24 hours and up +25.03% over the past month. Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Previous Close:
$47.88
Open:
$47.90
24h Volume:
533,228
Relative Volume:
1.54
Market Cap:
$2.21B
Revenue:
$45.95M
Net Income/Loss:
-$48.88M
P/E Ratio:
-
EPS:
-$1.11
Net Cash Flow:
$109.67M
1W Performance:
+4.69%
1M Performance:
+25.03%
6M Performance:
+96.23%
1Y Performance:
+147.52%
1-Day Range:
$45.95$48.10
1-Week Range:
$41.07$48.23
52-Week Range:
$17.55$51.10
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna IncSector
HealthcareIndustry
BiotechnologyPhone
650-338-3533Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS